Drug
Transdermal System Containing Progestin
Transdermal System Containing Progestin: highest development phase Phase 3, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Transdermal system containing progestin NCT06672016 | Phase 3 | Female Contraception |
Latest
No recent events.
Follow Transdermal System Containing Progestin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.